Hall MN - Search Results

1

Proteomic Landscape of Aldosterone-Producing Adenoma.

Swierczynska MM, Betz MJ, Colombi M, Dazert E, Jenö P, Moes S, Pfaff C, Glatz K, Reincke M, Beuschlein F, Donath MY, Hall MN. Swierczynska MM, et al. Among authors: hall mn. Hypertension. 2019 Feb;73(2):469-480. doi: 10.1161/HYPERTENSIONAHA.118.11733. Hypertension. 2019. PMID: 30580688 Free article.

2

PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.

Thedieck K, Polak P, Kim ML, Molle KD, Cohen A, Jenö P, Arrieumerlou C, Hall MN. Thedieck K, et al. Among authors: hall mn. PLoS One. 2007 Nov 21;2(11):e1217. doi: 10.1371/journal.pone.0001217. PLoS One. 2007. PMID: 18030348 Free PMC article.

3

Identification of the rapamycin-sensitive phosphorylation sites within the Ser/Thr-rich domain of the yeast Npr1 protein kinase.

Gander S, Bonenfant D, Altermatt P, Martin DE, Hauri S, Moes S, Hall MN, Jenoe P. Gander S, et al. Among authors: hall mn. Rapid Commun Mass Spectrom. 2008 Dec;22(23):3743-53. doi: 10.1002/rcm.3790. Rapid Commun Mass Spectrom. 2008. PMID: 18980262

4

An amino acid shuffle activates mTORC1.

Cohen A, Hall MN. Cohen A, et al. Among authors: hall mn. Cell. 2009 Feb 6;136(3):399-400. doi: 10.1016/j.cell.2009.01.021. Cell. 2009. PMID: 19203575 Free article.

5

The rapamycin-sensitive phosphoproteome reveals that TOR controls protein kinase A toward some but not all substrates.

Soulard A, Cremonesi A, Moes S, Schütz F, Jenö P, Hall MN. Soulard A, et al. Among authors: hall mn. Mol Biol Cell. 2010 Oct 1;21(19):3475-86. doi: 10.1091/mbc.E10-03-0182. Epub 2010 Aug 11. Mol Biol Cell. 2010. PMID: 20702584 Free PMC article.

6

Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction.

Colombi M, Molle KD, Benjamin D, Rattenbacher-Kiser K, Schaefer C, Betz C, Thiemeyer A, Regenass U, Hall MN, Moroni C. Colombi M, et al. Among authors: hall mn. Oncogene. 2011 Mar 31;30(13):1551-65. doi: 10.1038/onc.2010.539. Epub 2010 Dec 20. Oncogene. 2011. PMID: 21170086

7

mTOR signaling in disease.

Dazert E, Hall MN. Dazert E, et al. Among authors: hall mn. Curr Opin Cell Biol. 2011 Dec;23(6):744-55. doi: 10.1016/j.ceb.2011.09.003. Epub 2011 Sep 29. Curr Opin Cell Biol. 2011. PMID: 21963299 Review.

8

Rapamycin passes the torch: a new generation of mTOR inhibitors.

Benjamin D, Colombi M, Moroni C, Hall MN. Benjamin D, et al. Among authors: hall mn. Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80. doi: 10.1038/nrd3531. Nat Rev Drug Discov. 2011. PMID: 22037041 Review.

9

TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate complex sphingolipid synthesis.

Shimobayashi M, Oppliger W, Moes S, Jenö P, Hall MN. Shimobayashi M, et al. Among authors: hall mn. Mol Biol Cell. 2013 Mar;24(6):870-81. doi: 10.1091/mbc.E12-10-0753. Epub 2013 Jan 30. Mol Biol Cell. 2013. PMID: 23363605 Free PMC article.

10

Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.

Robitaille AM, Christen S, Shimobayashi M, Cornu M, Fava LL, Moes S, Prescianotto-Baschong C, Sauer U, Jenoe P, Hall MN. Robitaille AM, et al. Among authors: hall mn. Science. 2013 Mar 15;339(6125):1320-3. doi: 10.1126/science.1228771. Epub 2013 Feb 21. Science. 2013. PMID: 23429704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page